PAVmed Inc (PAVMZ)
USD 0.02
(32.0%)
USD 0.02
(32.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 33.11 Million USD | -38.65% |
| 2022 | 53.98 Million USD | -37.94% |
| 2021 | 86.97 Million USD | 339.76% |
| 2020 | 19.77 Million USD | 173.16% |
| 2019 | 7.24 Million USD | -14.78% |
| 2018 | 8.49 Million USD | 418.18% |
| 2017 | 1.63 Million USD | 88.38% |
| 2016 | 870.41 Thousand USD | -28.31% |
| 2015 | 1.21 Million USD | 44.18% |
| 2014 | 842.07 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 37.25 Million USD | 12.49% |
| 2024 Q2 | 39.41 Million USD | 5.8% |
| 2023 Q1 | 65.28 Million USD | 20.94% |
| 2023 FY | 33.11 Million USD | -38.65% |
| 2023 Q4 | 33.11 Million USD | -21.18% |
| 2023 Q3 | 42.02 Million USD | -21.73% |
| 2023 Q2 | 53.68 Million USD | -17.77% |
| 2022 Q4 | 53.98 Million USD | -25.51% |
| 2022 Q2 | 82.45 Million USD | -2.23% |
| 2022 Q1 | 84.33 Million USD | -3.04% |
| 2022 FY | 53.98 Million USD | -37.94% |
| 2022 Q3 | 72.46 Million USD | -12.11% |
| 2021 Q1 | 51.36 Million USD | 159.73% |
| 2021 FY | 86.97 Million USD | 339.76% |
| 2021 Q2 | 47.37 Million USD | -7.78% |
| 2021 Q4 | 86.97 Million USD | 102.34% |
| 2021 Q3 | 42.98 Million USD | -9.26% |
| 2020 Q1 | 10.11 Million USD | 39.69% |
| 2020 Q2 | 8.88 Million USD | -12.18% |
| 2020 Q3 | 10.5 Million USD | 18.26% |
| 2020 Q4 | 19.77 Million USD | 88.29% |
| 2020 FY | 19.77 Million USD | 173.16% |
| 2019 Q2 | 7.06 Million USD | 62.1% |
| 2019 Q1 | 4.35 Million USD | -48.74% |
| 2019 Q4 | 7.24 Million USD | 64.34% |
| 2019 Q3 | 4.4 Million USD | -37.6% |
| 2019 FY | 7.24 Million USD | -14.78% |
| 2018 Q3 | 9.39 Million USD | -16.36% |
| 2018 FY | 8.49 Million USD | 418.18% |
| 2018 Q4 | 8.49 Million USD | -9.59% |
| 2018 Q2 | 11.23 Million USD | 198.95% |
| 2018 Q1 | 3.75 Million USD | 129.25% |
| 2017 FY | 1.63 Million USD | 88.38% |
| 2017 Q2 | 226.48 Thousand USD | -79.3% |
| 2017 Q3 | 3.23 Million USD | 1327.38% |
| 2017 Q4 | 1.63 Million USD | -49.28% |
| 2017 Q1 | 1.09 Million USD | 25.7% |
| 2016 Q2 | 3.15 Million USD | 303.53% |
| 2016 Q1 | 781.29 Thousand USD | -35.65% |
| 2016 Q4 | 870.41 Thousand USD | -56.17% |
| 2016 FY | 870.41 Thousand USD | -28.31% |
| 2016 Q3 | 1.98 Million USD | -37.01% |
| 2015 Q2 | 573.07 Thousand USD | -27.53% |
| 2015 Q3 | 1.8 Million USD | 215.82% |
| 2015 FY | 1.21 Million USD | 44.18% |
| 2015 Q4 | 1.21 Million USD | -32.92% |
| 2015 Q1 | 790.78 Thousand USD | 0.0% |
| 2014 FY | 842.07 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acutus Medical, Inc. | 53.96 Million USD | 38.623% |
| Axonics, Inc. | 719.92 Million USD | 95.4% |
| INVO Bioscience, Inc. | 20.88 Million USD | -58.557% |
| CVRx, Inc. | 115.22 Million USD | 71.258% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 92.354% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -99.765% |
| MaxCyte, Inc. | 268.27 Million USD | 87.655% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 22.367% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 91.817% |
| Sintx Technologies, Inc. | 15.36 Million USD | -115.548% |
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -5.589% |
| Apyx Medical Corporation | 79.24 Million USD | 58.204% |
| Cutera, Inc. | 346.29 Million USD | 90.436% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -330.564% |
| NeuroPace, Inc. | 107.65 Million USD | 69.235% |
| IRIDEX Corporation | 34.43 Million USD | 3.824% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 88.232% |
| enVVeno Medical Corporation | 48.63 Million USD | 31.903% |
| TELA Bio, Inc. | 78.04 Million USD | 57.566% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 96.524% |
| UFP Technologies, Inc. | 404.13 Million USD | 91.805% |
| Modular Medical, Inc. | 13.8 Million USD | -139.871% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 21.175% |
| LENSAR, Inc. | 69.58 Million USD | 52.405% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.124% |
| Surmodics, Inc. | 185.73 Million USD | 82.168% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -208.658% |
| Inogen, Inc. | 326.19 Million USD | 89.847% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -530.358% |
| RxSight, Inc. | 182.55 Million USD | 81.858% |
| Nexalin Technology, Inc. | 3.63 Million USD | -811.888% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -21.448% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 84.853% |
| Nexalin Technology, Inc. | 3.63 Million USD | -811.888% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -963.124% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 93.345% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 95.887% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 76.913% |
| Dynatronics Corporation | 25.94 Million USD | -27.673% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -28.742% |
| InMode Ltd. | 863.28 Million USD | 96.164% |
| Bruker Corporation | 4.24 Billion USD | 99.221% |
| Movano Inc. | 9.42 Million USD | -251.544% |
| Orthofix Medical Inc. | 925.31 Million USD | 96.421% |
| FONAR Corporation | 214.24 Million USD | 84.542% |
| BioSig Technologies, Inc. | 1.79 Million USD | -1741.991% |
| Envoy Medical, Inc. | 7.64 Million USD | -333.495% |
| Align Technology, Inc. | 6.08 Billion USD | 99.456% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 87.762% |
| Talis Biomedical Corporation | 98.34 Million USD | 66.322% |
| Cerus Corporation | 197.74 Million USD | 83.252% |
| 908 Devices Inc. | 202.98 Million USD | 83.684% |
| Nemaura Medical Inc. | 14.56 Million USD | -127.415% |
| Outset Medical, Inc. | 313.8 Million USD | 89.446% |
| NanoVibronix, Inc. | 6.67 Million USD | -396.239% |
| Venus Concept Inc. | 93.65 Million USD | 64.637% |
| Telesis Bio, Inc. | 70.41 Million USD | 52.963% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 86.853% |
| Quipt Home Medical Corp. | 247.4 Million USD | 86.614% |
| IRadimed Corporation | 92.15 Million USD | 64.062% |
| Tenon Medical, Inc. | 6.34 Million USD | -421.97% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -255.736% |
| Pulmonx Corporation | 178.95 Million USD | 81.493% |
| iCAD, Inc. | 41.41 Million USD | 20.037% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -41.543% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -309.012% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 78.508% |
| SI-BONE, Inc. | 230.42 Million USD | 85.627% |
| Semler Scientific, Inc. | 78.06 Million USD | 57.575% |
| Biotricity, Inc. | 5.94 Million USD | -457.313% |
| Cytosorbents Corporation | 53.26 Million USD | 37.817% |
| DexCom, Inc. | 6.26 Billion USD | 99.471% |
| ZimVie Inc. | 1.2 Billion USD | 97.252% |
| Aethlon Medical, Inc. | 8.24 Million USD | -301.638% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 43.542% |
| IceCure Medical Ltd | 16.41 Million USD | -101.822% |
| Sight Sciences, Inc. | 166.65 Million USD | 80.127% |
| Insulet Corporation | 2.58 Billion USD | 98.72% |
| Profound Medical Corp. | 43.68 Million USD | 24.189% |
| electroCore, Inc. | 16.38 Million USD | -102.105% |
| Bioventus Inc. | 810.91 Million USD | 95.916% |
| InspireMD, Inc. | 47.64 Million USD | 30.485% |
| PAVmed Inc. | 33.11 Million USD | 0.0% |
| Nuwellis, Inc. | 9.77 Million USD | -238.987% |
| OrthoPediatrics Corp. | 449.58 Million USD | 92.633% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 43.542% |
| BrainsWay Ltd. | 62.97 Million USD | 47.407% |
| BIOLASE, Inc. | 35.1 Million USD | 5.647% |
| Beyond Air, Inc. | 56.96 Million USD | 41.857% |
| AxoGen, Inc. | 196.82 Million USD | 83.174% |
| Inari Medical, Inc. | 674.23 Million USD | 95.088% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -248.507% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -252.068% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.283% |
| Quanterix Corporation | 425.01 Million USD | 92.207% |
| Viveve Medical, Inc. | 25.91 Million USD | -27.808% |
| LivaNova PLC | 2.42 Billion USD | 98.637% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 68.047% |
| Varex Imaging Corporation | 1.24 Billion USD | 97.35% |
| Vivani Medical, Inc. | 45.79 Million USD | 27.683% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -208.744% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -255.736% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 38.357% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 98.103% |
| TransMedics Group, Inc. | 706.04 Million USD | 95.309% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 47.59% |
| NeuroMetrix, Inc. | 21.42 Million USD | -54.585% |
| Spectral AI, Inc. | 10.69 Million USD | -209.755% |
| Hyperfine, Inc. | 94.19 Million USD | 64.841% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 87.672% |
| Biomerica, Inc. | 9.25 Million USD | -257.888% |
| Bone Biologics Corporation | 3.73 Million USD | -786.065% |
| AVITA Medical, Inc. | 144.33 Million USD | 77.055% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -580.267% |
| Silk Road Medical, Inc | 265.3 Million USD | 87.517% |